Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Determining Pain Catastrophizing From Daily Pain App Assessment Data: Role of Computer-Based Classification.

Jamison RN, Xu X, Wan L, Edwards RR, Ross EL.

J Pain. 2018 Sep 29. pii: S1526-5900(18)30646-1. doi: 10.1016/j.jpain.2018.09.005. [Epub ahead of print]

PMID:
30273687
2.

Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States.

Ross EL, Zivin K, Maixner DF.

JAMA Psychiatry. 2018 Jul 1;75(7):713-722. doi: 10.1001/jamapsychiatry.2018.0768.

PMID:
29800956
3.

Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.

Freedberg KA, Kumarasamy N, Borre ED, Ross EL, Mayer KH, Losina E, Swaminathan S, Flanigan TP, Walensky RP.

AIDS Res Hum Retroviruses. 2018 Jun;34(6):486-497. doi: 10.1089/AID.2017.0258. Epub 2018 May 3.

4.

Unique Intradural Inflammatory Mass Containing Precipitated Morphine: Confirmatory Analysis by LESA-MS and MALDI-MS.

Kim AJ, Basu S, Glass C, Ross EL, Agar N, He Q, Calligaris D.

Pain Pract. 2018 Sep;18(7):889-894. doi: 10.1111/papr.12688. Epub 2018 Mar 30.

PMID:
29480977
5.

Efficacy of Vibrating Gloves for Chronic Hand Pain due to Osteoarthritis.

Jamison RN, Mei A, Edwards RR, Ross EL.

Pain Med. 2018 May 1;19(5):1044-1057. doi: 10.1093/pm/pnx230.

PMID:
29025096
6.

Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.

Waxman AB, McElderry HT, Gomberg-Maitland M, Burke MC, Ross EL, Bersohn MM, Pangarkar SS, Tarver JH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Thompson GB, Torres F, Rauck RL, Clagg K, Durst L, Li P, Morris M, Southall KL, Peterson L, Bourge RC.

Chest. 2017 Dec;152(6):1128-1134. doi: 10.1016/j.chest.2017.04.188. Epub 2017 Jun 3.

PMID:
28583617
7.

Integration of Mobile Health Technology in the Treatment of Chronic Pain: A Critical Review.

Sundararaman LV, Edwards RR, Ross EL, Jamison RN.

Reg Anesth Pain Med. 2017 Jul/Aug;42(4):488-498. doi: 10.1097/AAP.0000000000000621. Review.

PMID:
28570436
8.

Prevalence of chronic pain with neuropathic characteristics: a randomized telephone survey among medical center patients in Kuwait.

Zghoul N, Ross EL, Edwards RR, Ahmed A, Jamison RN.

J Pain Res. 2017 Apr 4;10:679-687. doi: 10.2147/JPR.S123966. eCollection 2017.

9.

A Pilot Comparison of a Smartphone App With or Without 2-Way Messaging Among Chronic Pain Patients: Who Benefits From a Pain App?

Jamison RN, Jurcik DC, Edwards RR, Huang CC, Ross EL.

Clin J Pain. 2017 Aug;33(8):676-686. doi: 10.1097/AJP.0000000000000455.

10.

Longitudinal trial of a smartphone pain application for chronic pain patients: Predictors of compliance and satisfaction.

Jamison RN, Mei A, Ross EL.

J Telemed Telecare. 2018 Feb;24(2):93-100. doi: 10.1177/1357633X16679049. Epub 2016 Nov 10.

PMID:
27831496
11.

Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial.

Ross EL, Hutton DW, Stein JD, Bressler NM, Jampol LM, Glassman AR; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2016 Aug 1;134(8):888-96. doi: 10.1001/jamaophthalmol.2016.1669.

PMID:
27280850
12.

Enhancing the Value of Preschool Vision Screenings.

Ross EL, Stein JD.

JAMA Ophthalmol. 2016 Jun 1;134(6):664-5. doi: 10.1001/jamaophthalmol.2016.0822. No abstract available.

PMID:
27077370
13.

Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men.

Ross EL, Cinti SK, Hutton DW.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):e61-7. doi: 10.1097/QAI.0000000000000987.

PMID:
26977749
14.
15.

Evaluation of prolonged epidural chloroprocaine for postoperative analgesia in infants.

Ross EL, Reiter PD, Murphy ME, Bielsky AR.

J Clin Anesth. 2015 Sep;27(6):463-9. doi: 10.1016/j.jclinane.2015.05.022. Epub 2015 Jul 26.

PMID:
26219196
16.

Chronic Pain, Comorbid Medical Conditions, and Associated Risk Factors in Kuwait: Gender and Nationality Differences.

Deeny MC, Al Hamdan E, Ross EL, Edwards RR, Huang CC, Jamison RN.

Pain Med. 2015 Nov;16(11):2204-11. doi: 10.1111/pme.12840. Epub 2015 Jun 27.

PMID:
26118589
17.

Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.

Ross EL, Heizer J, Mixon MA, Jorgensen J, Valdez CA, Czaja AS, Reiter PD.

Am J Health Syst Pharm. 2015 Apr 1;72(7):542-56. doi: 10.2146/ajhp140280.

PMID:
25788508
18.

The clinical role and cost-effectiveness of long-acting antiretroviral therapy.

Ross EL, Weinstein MC, Schackman BR, Sax PE, Paltiel AD, Walensky RP, Freedberg KA, Losina E.

Clin Infect Dis. 2015 Apr 1;60(7):1102-10. doi: 10.1093/cid/ciu1159. Epub 2015 Jan 12.

19.

Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.

Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL.

J Opioid Manag. 2014 Nov-Dec;10(6):375-82. doi: 10.5055/jom.2014.0234.

PMID:
25531955
20.

Validation of a brief Opioid Compliance Checklist for patients with chronic pain.

Jamison RN, Martel MO, Edwards RR, Qian J, Sheehan KA, Ross EL.

J Pain. 2014 Nov;15(11):1092-1101. doi: 10.1016/j.jpain.2014.07.007. Epub 2014 Aug 1.

21.

Comparison of 3 body size descriptors in critically ill obese children and adolescents: implications for medication dosing.

Ross EL, Jorgensen J, DeWitt PE, Okada C, Porter R, Haemer M, Reiter PD.

J Pediatr Pharmacol Ther. 2014 Apr;19(2):103-10. doi: 10.5863/1551-6776-19.2.103.

22.

Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.

Ouattara EN, Ross EL, Yazdanpanah Y, Wong AY, Robine M, Losina E, Moh R, Walensky RP, Danel C, Paltiel AD, Eholié SP, Freedberg KA, Anglaret X.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):294-302. doi: 10.1097/QAI.0000000000000166.

23.

Neuromodulation for intractable headaches.

Hassanzadeh R, Jones JC, Ross EL.

Curr Pain Headache Rep. 2014 Feb;18(2):392. doi: 10.1007/s11916-013-0392-1. Review.

PMID:
24488653
24.

Routine HIV screening in Portugal: clinical impact and cost-effectiveness.

Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD.

PLoS One. 2013 Dec 18;8(12):e84173. doi: 10.1371/journal.pone.0084173. eCollection 2013.

25.

Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.

Walensky RP, Ross EL, Kumarasamy N, Wood R, Noubary F, Paltiel AD, Nakamura YM, Godbole SV, Panchia R, Sanne I, Weinstein MC, Losina E, Mayer KH, Chen YQ, Wang L, McCauley M, Gamble T, Seage GR 3rd, Cohen MS, Freedberg KA.

N Engl J Med. 2013 Oct 31;369(18):1715-25. doi: 10.1056/NEJMsa1214720.

26.

The clinical impact of a false-positive urine cocaine screening result on a patient's pain management.

Kim JA, Ptolemy AS, Melanson SE, Janfaza DR, Ross EL.

Pain Med. 2015 Jun;16(6):1073-6. doi: 10.1111/pme.12265. Epub 2013 Oct 18.

PMID:
24138673
27.

Aberrant intrathecal pump refill: ultrasound-guided aspiration of a substantial quantity of subcutaneous hydromorphone.

Peccora CD, Ross EL, Hanna GM.

Reg Anesth Pain Med. 2013 Nov-Dec;38(6):544-6. doi: 10.1097/AAP.0000000000000008.

PMID:
24121607
28.

The impact of self-reported life stress on current impulsivity in cocaine dependent adults.

Ross EL, Yoon JH, Mahoney JJ 3rd, Omar Y, Newton TF, De La Garza R 2nd.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:113-9. doi: 10.1016/j.pnpbp.2013.06.002. Epub 2013 Jun 21.

29.

Affective symptoms and change in diabetes self-efficacy and glycaemic control.

Robertson SM, Amspoker AB, Cully JA, Ross EL, Naik AD.

Diabet Med. 2013 May;30(5):e189-96. doi: 10.1111/dme.12146.

30.

The relationship between lifetime stress and addiction severity in cocaine-dependent participants.

Mahoney JJ 3rd, Newton TF, Omar Y, Ross EL, De La Garza R 2nd.

Eur Neuropsychopharmacol. 2013 May;23(5):351-7. doi: 10.1016/j.euroneuro.2012.05.016. Epub 2012 Jun 28.

PMID:
22748418
31.

Relationship of negative affect and outcome of an opioid therapy trial among low back pain patients.

Jamison RN, Edwards RR, Liu X, Ross EL, Michna E, Warnick M, Wasan AD.

Pain Pract. 2013 Mar;13(3):173-81. doi: 10.1111/j.1533-2500.2012.00575.x. Epub 2012 Jun 11.

32.

Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers.

Yoon JH, Newton TF, Haile CN, Bordnick PS, Fintzy RE, Culbertson C, Mahoney JJ 3rd, Hawkins RY, Labounty KR, Ross EL, Aziziyeh AI, De La Garza R 2nd.

Addict Behav. 2013 Feb;38(2):1518-26. doi: 10.1016/j.addbeh.2012.03.022. Epub 2012 Mar 26.

33.

Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial.

Wasan AD, Ross EL, Michna E, Chibnik L, Greenfield SF, Weiss RD, Jamison RN.

J Pain. 2012 Feb;13(2):146-54. doi: 10.1016/j.jpain.2011.10.010. Epub 2012 Jan 14.

34.

Measuring patients' self-efficacy in understanding and using prescription medication.

Cameron KA, Ross EL, Clayman ML, Bergeron AR, Federman AD, Bailey SC, Davis TC, Wolf MS.

Patient Educ Couns. 2010 Sep;80(3):372-6. doi: 10.1016/j.pec.2010.06.029. Epub 2010 Jul 21.

35.

Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Jamison RN, Ross EL, Michna E, Chen LQ, Holcomb C, Wasan AD.

Pain. 2010 Sep;150(3):390-400. doi: 10.1016/j.pain.2010.02.033. Epub 2010 Mar 23.

36.

Nurses' comfort level with emergency interventions in the rural hospital setting.

Ross EL, Bell SE.

J Rural Health. 2009 Summer;25(3):296-302. doi: 10.1111/j.1748-0361.2009.00233.x.

PMID:
19566616
37.

Do implantable devices improve mood? Comparisons of chronic pain patients with or without an implantable device.

Jamison RN, Washington TA, Fanciullo GJ, Ross EL, McHugo GJ, Baird JC.

Neuromodulation. 2008 Oct;11(4):260-6. doi: 10.1111/j.1525-1403.2008.00173.x.

PMID:
22151138
38.

Patients with chronic pain on opioid therapy taking dronabinol: incidence of false negatives using radioimmunoassay.

Narang S, Wasan AD, Ross EL, Michna E, Chen JY, Jamison RN.

J Opioid Manag. 2008 Jan-Feb;4(1):21-6.

PMID:
18444444
39.

KADIAN (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain.

Ross EL, Hahn K.

Int J Clin Pract. 2008 Mar;62(3):471-9. doi: 10.1111/j.1742-1241.2007.01688.x. Review.

PMID:
18261077
40.

Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.

Narang S, Gibson D, Wasan AD, Ross EL, Michna E, Nedeljkovic SS, Jamison RN.

J Pain. 2008 Mar;9(3):254-64. Epub 2007 Dec 21.

PMID:
18088560
41.

Comment on Ballantyne and LaForge, Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129:235-55.

Jamison RN, Ross EL, Wasan AD, Michna E.

Pain. 2007 Nov;132(1-2):218-9; author reply 219. Epub 2007 Sep 17. No abstract available.

PMID:
17870238
42.
43.

Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings.

Michna E, Jamison RN, Pham LD, Ross EL, Janfaza D, Nedeljkovic SS, Narang S, Palombi D, Wasan AD.

Clin J Pain. 2007 Feb;23(2):173-9.

PMID:
17237667
44.

Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.

Zbar AP, Thomas H, Wilkinson RW, Wadhwa M, Syrigos KN, Ross EL, Dilger P, Allen-Mersh TG, Kmiot WA, Epenetos AA, Snary D, Bodmer WF.

Int J Colorectal Dis. 2005 Sep;20(5):403-14. Epub 2005 Apr 30.

PMID:
15864608
45.

Preparation of the patient for palliative procedures.

Ross EL, Abrahm J.

Surg Clin North Am. 2005 Apr;85(2):191-207, v. Review.

PMID:
15833466
46.

Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.

Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, Palombi D, Jamison RN.

J Pain Symptom Manage. 2004 Sep;28(3):250-8.

PMID:
15336337
47.

Evaluation of a transgenic mouse model for anti-human CEA radioimmunotherapeutics.

Wilkinson RW, Ross EL, Ellison D, Zimmermann W, Snary D, Mather SJ.

J Nucl Med. 2002 Oct;43(10):1368-76.

48.

Chronic pain: relief is out there.

Ross EL.

Health News. 2002 Mar;8(3):3. No abstract available.

PMID:
11910845
49.

Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores.

Wilkinson RW, Lee-MacAry AE, Davies D, Snary D, Ross EL.

J Immunol Methods. 2001 Dec 1;258(1-2):183-91.

PMID:
11684135
50.

Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.

Wilkinson RW, Ross EL, Poulsom R, Ilyas M, Straub J, Snary D, Bodmer WF, Mather SJ.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10256-60. Epub 2001 Aug 21.

Supplemental Content

Support Center